Buy Atossa Genetics Stock | ATOS Stock Price & Latest News | Public
ATOS

Atossa Genetics

$0.00 (0.00%)Today
    Small Market Cap

    About ATOS

    Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.3
    -0.45
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.45

    Actual EPS
    Q4 2020

    Stats

    Market Cap$15,52M
    Volume2,65k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.08
    1 Year Low$0.76
    Open$1.51
    High$1.52
    Low$1.48

    Buy any stock with any amount of money.

    Download the App
    Download the app